Cargando…

A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2

We recently described a novel receptor cross-talk mechanism in neutrophils, unique in that the signals generated by the PAF receptor (PAFR) and the ATP receptor (P2Y(2)R) transfer formyl peptide receptor 1 (FPR1) from a desensitized (non-signaling) state back to an actively signaling state (Forsman...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabl, Michael, Winther, Malene, Skovbakke, Sarah Line, Bylund, Johan, Dahlgren, Claes, Forsman, Huamei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193777/ https://www.ncbi.nlm.nih.gov/pubmed/25303226 http://dx.doi.org/10.1371/journal.pone.0109516

Ejemplares similares

Data on human neutrophil activation induced by pepducins with amino acid sequences derived from β2AR and CXCR4
por: Holdfeldt, André, et al.
Publicado: (2016)

Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question
por: Winther, Malene, et al.
Publicado: (2017)

The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP(2)-binding peptide
por: Forsman, Huamei, et al.
Publicado: (2010)

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
por: Zhuang, Youwen, et al.
Publicado: (2022)

Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex
por: Lind, Simon, et al.
Publicado: (2020)

Data showing effects of a PI3K-δ inhibitor on neutrophil superoxide production during FPR2 activation and reactivation
por: Holdfeldt, André, et al.
Publicado: (2020)

Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction
por: Koenig, Andrew L., et al.
Publicado: (2021)

FPR Ligands
por: Liu, Ying, et al.
Publicado: (2013)

Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
por: Cattaneo, Fabio, et al.
Publicado: (2013)

Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis
por: Crocetti, Letizia, et al.
Publicado: (2021)

Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages
por: Marutani, Takayuki, et al.
Publicado: (2021)

Formylated MHC Class Ib Binding Peptides Activate Both Human and Mouse Neutrophils Primarily through Formyl Peptide Receptor 1
por: Winther, Malene, et al.
Publicado: (2016)

The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin against Ultraviolet B Radiation
por: Martinez, Renata M., et al.
Publicado: (2020)

Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism
por: Cristiano, Claudia, et al.
Publicado: (2022)

Agonist concentration–dependent changes in FPR1 conformation lead to biased signaling for selective activation of phagocyte functions
por: Wang, Junlin, et al.
Publicado: (2022)

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA
por: Cussell, Peter J. G., et al.
Publicado: (2019)

Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis
por: Ren, Tingting, et al.
Publicado: (2023)

N-Formylpeptides Induce Two Distinct Concentration Optima for Mouse Neutrophil Chemotaxis by Differential Interaction with Two N-Formylpeptide Receptor (Fpr) Subtypes: Molecular Characterization of Fpr2, a Second Mouse Neutrophil Fpr
por: Hartt, Jennifer K., et al.
Publicado: (1999)

The ambiguous role of FPR1 in immunity and inflammation
por: Vacchelli, Erika, et al.
Publicado: (2020)

FPR2: A Novel Promising Target for the Treatment of Influenza
por: Alessi, Marie-Christine, et al.
Publicado: (2017)

Decreased Placental FPR2 in Early Pregnancies That Later Developed Small-For-Gestation Age: A Potential Role of FPR2 in the Regulation of Epithelial-Mesenchymal Transition
por: Murthi, Padma, et al.
Publicado: (2020)

The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures
por: Trojan, Ewa, et al.
Publicado: (2021)

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
por: Petri, Marcelo H., et al.
Publicado: (2015)

Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
por: Li, Anna, et al.
Publicado: (2020)

Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

FPR1 is the plague receptor on host immune cells
por: Osei-Owusu, Patrick, et al.
Publicado: (2019)

Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases
por: Ammendola, Rosario, et al.
Publicado: (2021)

Neutrophil Infiltration of the Colon Is Independent of the FPR1 yet FPR1 Deficient Mice Show Differential Susceptibilities to Acute Versus Chronic Induced Colitis
por: Farooq, Shukkur M., et al.
Publicado: (2012)

Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways
por: Tylek, Kinga, et al.
Publicado: (2021)

ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland
por: Wang, Ching-Shuen, et al.
Publicado: (2016)

Structural basis of FPR2 in recognition of Aβ(42) and neuroprotection by humanin
por: Zhu, Ya, et al.
Publicado: (2022)

FPR1 mediates the tumorigenicity of human cervical cancer cells
por: Cao, Guangming, et al.
Publicado: (2018)

Application of small molecule FPR1 antagonists in the treatment of cancers
por: Ahmet, Djevdet S., et al.
Publicado: (2020)

Role of formyl peptide receptor 2 (FPR2) in the normal brain and in neurological conditions
por: Ong, Wei-Yi, et al.
Publicado: (2019)

The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus
por: Rahman, Fryad, et al.
Publicado: (2018)

FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
por: Hou, Xi-Lu, et al.
Publicado: (2017)

Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
por: Wickstead, Edward S., et al.
Publicado: (2020)

WKYMVm/FPR2 Alleviates Spinal Cord Injury by Attenuating the Inflammatory Response of Microglia
por: Zhang, Wenwu, et al.
Publicado: (2022)

Keratinocytes use FPR2 to detect Staphylococcus aureus and initiate antimicrobial skin defense
por: Lebtig, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rle2hj4sesk385uesog501v24q